HLA-DPB1 and myeloid sarcoma: HLA-DRB1*0405 and HLA-DPB1*0301 were found to be MS susceptibility genes21, whereas HLA-DRB1*1602 and HLA-DPB1*0501 conferred susceptibility only to anti-AQP4 antibody-positive NMO22.